The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

Andrew Feldman, CEO of Cerebras, says there's tremendous demand from every AI company for DeepSeek's efficient open-source ...

That means Mr. Liang had a cornucopia of technical talent at his disposal, all galvanized by the challenge of doing AI ...

Rheumatoid arthritis is a crippling condition affecting 1.3 million people. To date, the standard of care has been to head off the progression of inflammation through trial-and-error treatment with a ...

Cerebras Systems (a client of Cambrian-AI Research) announced a new foundation model co-developed with partner The Mayo Clinic, that can identify the best medical therapy for Rheumatoid Arthritis.

Cerebras Systems, a leading innovator in artificial intelligence (AI) hardware, is turning heads with its groundbreaking technology and plans to go public. Founded in 2015 by Andrew Feldman and a team ...

A rout in public markets will also ripple through to private companies. In 2024 venture capitalists invested $132bn in AI ...

Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence tools to advance patient care, today at the JP Morgan Healthcare ...

DeepSeek’s breakthrough AI model disrupts markets, slashing costs, shaking U.S. tech giants, and raising global AI stakes.

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

ROCHESTER, Minn. & SUNNYVALE, Calif., January 14, 2025--(BUSINESS WIRE)--Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence tools ...